Atlas Trials

Phase 1, Febuxostat XR Relative Bioavailability Study

Clinical trial NCT02504320 · COMPLETED

Trial details

NCT number
NCT02504320
Sponsor
Takeda
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2015-08-01
Primary completion
2015-09-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.